CD31 Antibody - Global and China Top Players Market Share and Ranking 2023
According to the Latest Research Report,, the global market for CD31 Antibody should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
Growing patient base, launch of novel CD31 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD31 antibody market revenue.
CD31 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target CD31 in human, mouse, rat, rabbit and pig samples.
This report studies and analyses global CD31 Antibody status and future trends, helps the client to determine the CD31 Antibody market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for CD31 Antibody, and provides market size (in L & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global CD31 Antibody market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (L)
(2) Global CD31 Antibody sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (L)
(3) China CD31 Antibody sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (L)
(4) Global CD31 Antibody key consuming regions, consumption quantity, consumption value and demand structure
(5) Global CD31 Antibody key producing regions, capacity, production, and year over year growth
(6) CD31 Antibody industry chains, upstream, midstream and downstream
Market segment by players, this report covers
BosterBio
Bio-Rad
Bioss
Thermo Fisher Scientific
NSJ Bioreagents
R and D Systems
Abcam
BioLegend
GeneTex
Novus Biologicals
SouthernBiotech
LifeSpan BioSciences
Enzo Life Sciences
Bethyl Laboratories
Abbexa
ProSci
Proteintech
Synaptic Systems
BIOCARE MEDICAL
CUSABIO Technology
Absolute Antibody
EpiGentek
Biorbyt
Wuhan Fine Biotech
Sino Biological
Market segment by Type, covers
Monoclonal
Polyclonal
Market segment by Application, can be divided into
Immunochemistry (IHC)
Immunofluorescence (IF)
Western Blot (WB)
Immunocytochemistry (ICC)
ELISA
Others
Key Regions Covered in This Report Are:
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe CD31 Antibody product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global CD31 Antibody market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China CD31 Antibody market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of CD31 Antibody, percent & CAGR, 2018-2029
Chapter 5: CD31 Antibody industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 CD31 Antibody Definition
1.2 Global CD31 Antibody Market Size and Forecast
1.2.1 By Consumption Value, Global CD31 Antibody Market Size，2018-2029
1.2.2 By Sales Quantity, Global CD31 Antibody Market Size，2018-2029
1.2.3 Global CD31 Antibody Average Selling Price (ASP)，2018-2029
1.3 China CD31 Antibody Market Size and Forecast
1.3.1 By Consumption Value, China CD31 Antibody Market Size，2018-2029
1.3.2 By Sales Quantity, China CD31 Antibody Market Size，2018-2029
1.3.3 China CD31 Antibody Average Selling Price (ASP)， 2018-2029
1.4 Share of China CD31 Antibody Market with Respect to the Global Market
1.4.1 By Consumption Value, China CD31 Antibody Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China CD31 Antibody Market Share in Global, 2018-2029
1.4.3 CD31 Antibody Market Size: China VS Global, 2018-2029
1.5 CD31 Antibody Market Dynamics
1.5.1 CD31 Antibody Market Drivers
1.5.2 CD31 Antibody Market Restraints
1.5.3 CD31 Antibody Industry Trends
1.5.4 CD31 Antibody Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of CD31 Antibody, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of CD31 Antibody, Global Market Share by Company, 2018-2023
2.3 CD31 Antibody Average Selling Price (ASP) by Company, 2018-2023
2.4 Global CD31 Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global CD31 Antibody Concentration Ratio
2.6 Global CD31 Antibody Mergers & Acquisitions, Expansion Plans
2.7 Global CD31 Antibody Manufacturers Product Type
2.8 Head Office and CD31 Antibody Production Site of Key Manufacturer
2.9 CD31 Antibody Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of CD31 Antibody, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of CD31 Antibody, China Market Share by Company, 2018-2023
3.3 China CD31 Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global CD31 Antibody Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global CD31 Antibody Capacity by Region
4.3 Global CD31 Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global CD31 Antibody Production by Region, 2018-2029
4.5 Global CD31 Antibody Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 CD31 Antibody Industry Chain
5.2 CD31 Antibody Upstream Analysis
5.2.1 CD31 Antibody Core Raw Materials
5.2.2 Main Manufacturers of CD31 Antibody Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 CD31 Antibody Production Mode
5.6 CD31 Antibody Procurement Model
5.7 CD31 Antibody Industry Sales Model and Sales Channels
5.7.1 CD31 Antibody Sales Model
5.7.2 CD31 Antibody Typical Distributors
6 Sights by Type
6.1 CD31 Antibody Classification
6.1.1 Monoclonal
6.1.2 Polyclonal
6.2 By Type, Global CD31 Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global CD31 Antibody Consumption Value, 2018-2029
6.4 By Type, Global CD31 Antibody Sales Quantity, 2018-2029
6.5 By Type, Global CD31 Antibody Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 CD31 Antibody Segment by Application
7.1.1 Immunochemistry (IHC)
7.1.2 Immunofluorescence (IF)
7.1.3 Western Blot (WB)
7.1.4 Immunocytochemistry (ICC)
7.1.5 ELISA
7.1.6 Others
7.2 By Application, Global CD31 Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global CD31 Antibody Consumption Value, 2018-2029
7.4 By Application, Global CD31 Antibody Sales Quantity, 2018-2029
7.5 By Application, Global CD31 Antibody Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global CD31 Antibody Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global CD31 Antibody Consumption Value, 2018-2029
8.3 By Region, Global CD31 Antibody Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America CD31 Antibody & Forecasts, 2018-2029
8.4.2 By Country, North America CD31 Antibody Market Size Market Share
8.5 Europe
8.5.1 Europe CD31 Antibody Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe CD31 Antibody Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific CD31 Antibody Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific CD31 Antibody Market Size Market Share
8.7 South America
8.7.1 South America CD31 Antibody Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America CD31 Antibody Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global CD31 Antibody Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global CD31 Antibody Consumption Value, 2018-2029
9.3 By Country, Global CD31 Antibody Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. CD31 Antibody Market Size, 2018-2029
9.4.2 By Type, U.S. CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe CD31 Antibody Market Size, 2018-2029
9.5.2 By Type, Europe CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China CD31 Antibody Market Size, 2018-2029
9.6.2 By Type, China CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan CD31 Antibody Market Size, 2018-2029
9.7.2 By Type, Japan CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea CD31 Antibody Market Size, 2018-2029
9.8.2 By Type, South Korea CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia CD31 Antibody Market Size, 2018-2029
9.9.2 By Type, Southeast Asia CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India CD31 Antibody Market Size, 2018-2029
9.10.2 By Type, India CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa CD31 Antibody Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 BosterBio
10.1.1 BosterBio Company Information, Head Office, Market Area, and Industry Position
10.1.2 BosterBio CD31 Antibody Models, Specifications, and Application
10.1.3 BosterBio CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 BosterBio Company Profile and Main Business
10.1.5 BosterBio Recent Developments
10.2 Bio-Rad
10.2.1 Bio-Rad Company Information, Head Office, Market Area, and Industry Position
10.2.2 Bio-Rad CD31 Antibody Models, Specifications, and Application
10.2.3 Bio-Rad CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Bio-Rad Company Profile and Main Business
10.2.5 Bio-Rad Recent Developments
10.3 Bioss
10.3.1 Bioss Company Information, Head Office, Market Area, and Industry Position
10.3.2 Bioss CD31 Antibody Models, Specifications, and Application
10.3.3 Bioss CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Bioss Company Profile and Main Business
10.3.5 Bioss Recent Developments
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
10.4.2 Thermo Fisher Scientific CD31 Antibody Models, Specifications, and Application
10.4.3 Thermo Fisher Scientific CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Thermo Fisher Scientific Company Profile and Main Business
10.4.5 Thermo Fisher Scientific Recent Developments
10.5 NSJ Bioreagents
10.5.1 NSJ Bioreagents Company Information, Head Office, Market Area, and Industry Position
10.5.2 NSJ Bioreagents CD31 Antibody Models, Specifications, and Application
10.5.3 NSJ Bioreagents CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 NSJ Bioreagents Company Profile and Main Business
10.5.5 NSJ Bioreagents Recent Developments
10.6 R and D Systems
10.6.1 R and D Systems Company Information, Head Office, Market Area, and Industry Position
10.6.2 R and D Systems CD31 Antibody Models, Specifications, and Application
10.6.3 R and D Systems CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 R and D Systems Company Profile and Main Business
10.6.5 R and D Systems Recent Developments
10.7 Abcam
10.7.1 Abcam Company Information, Head Office, Market Area, and Industry Position
10.7.2 Abcam CD31 Antibody Models, Specifications, and Application
10.7.3 Abcam CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Abcam Company Profile and Main Business
10.7.5 Abcam Recent Developments
10.8 BioLegend
10.8.1 BioLegend Company Information, Head Office, Market Area, and Industry Position
10.8.2 BioLegend CD31 Antibody Models, Specifications, and Application
10.8.3 BioLegend CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 BioLegend Company Profile and Main Business
10.8.5 BioLegend Recent Developments
10.9 GeneTex
10.9.1 GeneTex Company Information, Head Office, Market Area, and Industry Position
10.9.2 GeneTex CD31 Antibody Models, Specifications, and Application
10.9.3 GeneTex CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 GeneTex Company Profile and Main Business
10.9.5 GeneTex Recent Developments
10.10 Novus Biologicals
10.10.1 Novus Biologicals Company Information, Head Office, Market Area, and Industry Position
10.10.2 Novus Biologicals CD31 Antibody Models, Specifications, and Application
10.10.3 Novus Biologicals CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Novus Biologicals Company Profile and Main Business
10.10.5 Novus Biologicals Recent Developments
10.11 SouthernBiotech
10.11.1 SouthernBiotech Company Information, Head Office, Market Area, and Industry Position
10.11.2 SouthernBiotech CD31 Antibody Models, Specifications, and Application
10.11.3 SouthernBiotech CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 SouthernBiotech Company Profile and Main Business
10.11.5 SouthernBiotech Recent Developments
10.12 LifeSpan BioSciences
10.12.1 LifeSpan BioSciences Company Information, Head Office, Market Area, and Industry Position
10.12.2 LifeSpan BioSciences CD31 Antibody Models, Specifications, and Application
10.12.3 LifeSpan BioSciences CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 LifeSpan BioSciences Company Profile and Main Business
10.12.5 LifeSpan BioSciences Recent Developments
10.13 Enzo Life Sciences
10.13.1 Enzo Life Sciences Company Information, Head Office, Market Area, and Industry Position
10.13.2 Enzo Life Sciences CD31 Antibody Models, Specifications, and Application
10.13.3 Enzo Life Sciences CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Enzo Life Sciences Company Profile and Main Business
10.13.5 Enzo Life Sciences Recent Developments
10.14 Bethyl Laboratories
10.14.1 Bethyl Laboratories Company Information, Head Office, Market Area, and Industry Position
10.14.2 Bethyl Laboratories CD31 Antibody Models, Specifications, and Application
10.14.3 Bethyl Laboratories CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Bethyl Laboratories Company Profile and Main Business
10.14.5 Bethyl Laboratories Recent Developments
10.15 Abbexa
10.15.1 Abbexa Company Information, Head Office, Market Area, and Industry Position
10.15.2 Abbexa CD31 Antibody Models, Specifications, and Application
10.15.3 Abbexa CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Abbexa Company Profile and Main Business
10.15.5 Abbexa Recent Developments
10.16 ProSci
10.16.1 ProSci Company Information, Head Office, Market Area, and Industry Position
10.16.2 ProSci CD31 Antibody Models, Specifications, and Application
10.16.3 ProSci CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 ProSci Company Profile and Main Business
10.16.5 ProSci Recent Developments
10.17 Proteintech
10.17.1 Proteintech Company Information, Head Office, Market Area, and Industry Position
10.17.2 Proteintech CD31 Antibody Models, Specifications, and Application
10.17.3 Proteintech CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Proteintech Company Profile and Main Business
10.17.5 Proteintech Recent Developments
10.18 Synaptic Systems
10.18.1 Synaptic Systems Company Information, Head Office, Market Area, and Industry Position
10.18.2 Synaptic Systems CD31 Antibody Models, Specifications, and Application
10.18.3 Synaptic Systems CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Synaptic Systems Company Profile and Main Business
10.18.5 Synaptic Systems Recent Developments
10.19 BIOCARE MEDICAL
10.19.1 BIOCARE MEDICAL Company Information, Head Office, Market Area, and Industry Position
10.19.2 BIOCARE MEDICAL CD31 Antibody Models, Specifications, and Application
10.19.3 BIOCARE MEDICAL CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 BIOCARE MEDICAL Company Profile and Main Business
10.19.5 BIOCARE MEDICAL Recent Developments
10.20 CUSABIO Technology
10.20.1 CUSABIO Technology Company Information, Head Office, Market Area, and Industry Position
10.20.2 CUSABIO Technology CD31 Antibody Models, Specifications, and Application
10.20.3 CUSABIO Technology CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.20.4 CUSABIO Technology Company Profile and Main Business
10.20.5 CUSABIO Technology Recent Developments
10.21 Absolute Antibody
10.21.1 Absolute Antibody Company Information, Head Office, Market Area, and Industry Position
10.21.2 Absolute Antibody CD31 Antibody Models, Specifications, and Application
10.21.3 Absolute Antibody CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.21.4 Absolute Antibody Company Profile and Main Business
10.21.5 Absolute Antibody Recent Developments
10.22 EpiGentek
10.22.1 EpiGentek Company Information, Head Office, Market Area, and Industry Position
10.22.2 EpiGentek CD31 Antibody Models, Specifications, and Application
10.22.3 EpiGentek CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.22.4 EpiGentek Company Profile and Main Business
10.22.5 EpiGentek Recent Developments
10.23 Biorbyt
10.23.1 Biorbyt Company Information, Head Office, Market Area, and Industry Position
10.23.2 Biorbyt CD31 Antibody Models, Specifications, and Application
10.23.3 Biorbyt CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.23.4 Biorbyt Company Profile and Main Business
10.23.5 Biorbyt Recent Developments
10.24 Wuhan Fine Biotech
10.24.1 Wuhan Fine Biotech Company Information, Head Office, Market Area, and Industry Position
10.24.2 Wuhan Fine Biotech CD31 Antibody Models, Specifications, and Application
10.24.3 Wuhan Fine Biotech CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.24.4 Wuhan Fine Biotech Company Profile and Main Business
10.24.5 Wuhan Fine Biotech Recent Developments
10.25 Sino Biological
10.25.1 Sino Biological Company Information, Head Office, Market Area, and Industry Position
10.25.2 Sino Biological CD31 Antibody Models, Specifications, and Application
10.25.3 Sino Biological CD31 Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.25.4 Sino Biological Company Profile and Main Business
10.25.5 Sino Biological Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. CD31 Antibody Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. CD31 Antibody Market Restraints
Table 3. CD31 Antibody Market Trends
Table 4. CD31 Antibody Industry Policy
Table 5. Global CD31 Antibody Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global CD31 Antibody Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global CD31 Antibody Sales Quantity by Company, (2018-2023) & (L), Ranked Based on Sales in 2022
Table 8. Global CD31 Antibody Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global CD31 Antibody Average Selling Price (ASP) by Company, (2018-2023) & (US$/L)
Table 10. Global CD31 Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global CD31 Antibody Mergers & Acquisitions, Expansion Plans
Table 12. Global CD31 Antibody Manufacturers Product Type
Table 13. Head Office and CD31 Antibody Production Site of Key Manufacturer
Table 14. CD31 Antibody Capacity of Major Manufacturers and Future Plan
Table 15. China CD31 Antibody Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China CD31 Antibody Sales Quantity by Company, (2018-2023) & (L), Ranked Based on Sales in 2022
Table 17. China CD31 Antibody Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global CD31 Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029, (L)
Table 19. Global CD31 Antibody Production by Region, 2018-2023, (L)
Table 20. Global CD31 Antibody Production Forecast by Region, 2024-2029, (L)
Table 21. Global Key Players of CD31 Antibody Upstream (Raw Materials)
Table 22. Global CD31 Antibody Typical Customers
Table 23. CD31 Antibody Typical Distributors
Table 24. By Type, Global CD31 Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global CD31 Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global CD31 Antibody Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global CD31 Antibody Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global CD31 Antibody Sales Quantity, 2018-2029, (L)
Table 29. By Country, Global CD31 Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global CD31 Antibody Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global CD31 Antibody Consumption Value Market Share, 2018-2029
Table 32. By Country, Global CD31 Antibody Sales Quantity, 2018-2029, (L)
Table 33. By Country, Global CD31 Antibody Sales Quantity Market Share, 2018-2029
Table 34. BosterBio Company Information, Head Office, Market Area, and Industry Position
Table 35. BosterBio CD31 Antibody Models, Specifications, and Application
Table 36. BosterBio CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 37. BosterBio Company Profile and Main Business
Table 38. BosterBio Recent Developments
Table 39. Bio-Rad Company Information, Head Office, Market Area, and Industry Position
Table 40. Bio-Rad CD31 Antibody Models, Specifications, and Application
Table 41. Bio-Rad CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 42. Bio-Rad Company Profile and Main Business
Table 43. Bio-Rad Recent Developments
Table 44. Bioss Company Information, Head Office, Market Area, and Industry Position
Table 45. Bioss CD31 Antibody Models, Specifications, and Application
Table 46. Bioss CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 47. Bioss Company Profile and Main Business
Table 48. Bioss Recent Developments
Table 49. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
Table 50. Thermo Fisher Scientific CD31 Antibody Models, Specifications, and Application
Table 51. Thermo Fisher Scientific CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 52. Thermo Fisher Scientific Company Profile and Main Business
Table 53. Thermo Fisher Scientific Recent Developments
Table 54. NSJ Bioreagents Company Information, Head Office, Market Area, and Industry Position
Table 55. NSJ Bioreagents CD31 Antibody Models, Specifications, and Application
Table 56. NSJ Bioreagents CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 57. NSJ Bioreagents Company Profile and Main Business
Table 58. NSJ Bioreagents Recent Developments
Table 59. R and D Systems Company Information, Head Office, Market Area, and Industry Position
Table 60. R and D Systems CD31 Antibody Models, Specifications, and Application
Table 61. R and D Systems CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 62. R and D Systems Company Profile and Main Business
Table 63. R and D Systems Recent Developments
Table 64. Abcam Company Information, Head Office, Market Area, and Industry Position
Table 65. Abcam CD31 Antibody Models, Specifications, and Application
Table 66. Abcam CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 67. Abcam Company Profile and Main Business
Table 68. Abcam Recent Developments
Table 69. BioLegend Company Information, Head Office, Market Area, and Industry Position
Table 70. BioLegend CD31 Antibody Models, Specifications, and Application
Table 71. BioLegend CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 72. BioLegend Company Profile and Main Business
Table 73. BioLegend Recent Developments
Table 74. GeneTex Company Information, Head Office, Market Area, and Industry Position
Table 75. GeneTex CD31 Antibody Models, Specifications, and Application
Table 76. GeneTex CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 77. GeneTex Company Profile and Main Business
Table 78. GeneTex Recent Developments
Table 79. Novus Biologicals Company Information, Head Office, Market Area, and Industry Position
Table 80. Novus Biologicals CD31 Antibody Models, Specifications, and Application
Table 81. Novus Biologicals CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 82. Novus Biologicals Company Profile and Main Business
Table 83. Novus Biologicals Recent Developments
Table 84. SouthernBiotech Company Information, Head Office, Market Area, and Industry Position
Table 85. SouthernBiotech CD31 Antibody Models, Specifications, and Application
Table 86. SouthernBiotech CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 87. SouthernBiotech Company Profile and Main Business
Table 88. SouthernBiotech Recent Developments
Table 89. LifeSpan BioSciences Company Information, Head Office, Market Area, and Industry Position
Table 90. LifeSpan BioSciences CD31 Antibody Models, Specifications, and Application
Table 91. LifeSpan BioSciences CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 92. LifeSpan BioSciences Company Profile and Main Business
Table 93. LifeSpan BioSciences Recent Developments
Table 94. Enzo Life Sciences Company Information, Head Office, Market Area, and Industry Position
Table 95. Enzo Life Sciences CD31 Antibody Models, Specifications, and Application
Table 96. Enzo Life Sciences CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 97. Enzo Life Sciences Company Profile and Main Business
Table 98. Enzo Life Sciences Recent Developments
Table 99. Bethyl Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 100. Bethyl Laboratories CD31 Antibody Models, Specifications, and Application
Table 101. Bethyl Laboratories CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 102. Bethyl Laboratories Company Profile and Main Business
Table 103. Bethyl Laboratories Recent Developments
Table 104. Abbexa Company Information, Head Office, Market Area, and Industry Position
Table 105. Abbexa CD31 Antibody Models, Specifications, and Application
Table 106. Abbexa CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 107. Abbexa Company Profile and Main Business
Table 108. Abbexa Recent Developments
Table 109. ProSci Company Information, Head Office, Market Area, and Industry Position
Table 110. ProSci CD31 Antibody Models, Specifications, and Application
Table 111. ProSci CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 112. ProSci Company Profile and Main Business
Table 113. ProSci Recent Developments
Table 114. Proteintech Company Information, Head Office, Market Area, and Industry Position
Table 115. Proteintech CD31 Antibody Models, Specifications, and Application
Table 116. Proteintech CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 117. Proteintech Company Profile and Main Business
Table 118. Proteintech Recent Developments
Table 119. Synaptic Systems Company Information, Head Office, Market Area, and Industry Position
Table 120. Synaptic Systems CD31 Antibody Models, Specifications, and Application
Table 121. Synaptic Systems CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 122. Synaptic Systems Company Profile and Main Business
Table 123. Synaptic Systems Recent Developments
Table 124. BIOCARE MEDICAL Company Information, Head Office, Market Area, and Industry Position
Table 125. BIOCARE MEDICAL CD31 Antibody Models, Specifications, and Application
Table 126. BIOCARE MEDICAL CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 127. BIOCARE MEDICAL Company Profile and Main Business
Table 128. BIOCARE MEDICAL Recent Developments
Table 129. CUSABIO Technology Company Information, Head Office, Market Area, and Industry Position
Table 130. CUSABIO Technology CD31 Antibody Models, Specifications, and Application
Table 131. CUSABIO Technology CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 132. CUSABIO Technology Company Profile and Main Business
Table 133. CUSABIO Technology Recent Developments
Table 134. Absolute Antibody CD31 Antibody Company Information, Head Office, Market Area, and Industry Position
Table 135. Absolute Antibody CD31 Antibody Models, Specifications, and Application
Table 136. Absolute Antibody CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 137. Absolute Antibody Company Profile and Main Business
Table 138. Absolute Antibody Recent Developments
Table 139. EpiGentek Company Information, Head Office, Market Area, and Industry Position
Table 140. EpiGentek CD31 Antibody Models, Specifications, and Application
Table 141. EpiGentek CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 142. EpiGentek Company Profile and Main Business
Table 143. EpiGentek Recent Developments
Table 144. Biorbyt Company Information, Head Office, Market Area, and Industry Position
Table 145. Biorbyt CD31 Antibody Models, Specifications, and Application
Table 146. Biorbyt CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 147. Biorbyt Company Profile and Main Business
Table 148. Biorbyt Recent Developments
Table 149. Wuhan Fine Biotech Company Information, Head Office, Market Area, and Industry Position
Table 150. Wuhan Fine Biotech CD31 Antibody Models, Specifications, and Application
Table 151. Wuhan Fine Biotech CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 152. Wuhan Fine Biotech Company Profile and Main Business
Table 153. Wuhan Fine Biotech Recent Developments
Table 154. Sino Biological Company Information, Head Office, Market Area, and Industry Position
Table 155. Sino Biological CD31 Antibody Models, Specifications, and Application
Table 156. Sino Biological CD31 Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 157. Sino Biological Company Profile and Main Business
Table 158. Sino Biological Recent Developments
List of Figures
Figure 1. CD31 Antibody Picture
Figure 2. Global CD31 Antibody Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global CD31 Antibody Sales Quantity, (L) & (2018-2029)
Figure 4. Global CD31 Antibody Average Selling Price (ASP), (2018-2029) & (US$/L)
Figure 5. China CD31 Antibody Consumption Value, (US$ million) & (2018-2029)
Figure 6. China CD31 Antibody Sales Quantity (L) & (2018-2029)
Figure 7. China CD31 Antibody Average Selling Price (ASP), (US$/L) & (2018-2029)
Figure 8. By Consumption Value, China CD31 Antibody Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China CD31 Antibody Market Share of Global, 2018-2029
Figure 10. Global CD31 Antibody Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China CD31 Antibody Key Participants, Market Share, 2022
Figure 12. Global CD31 Antibody Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global CD31 Antibody Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global CD31 Antibody Production Market Share & Forecast by Region, 2018-2029
Figure 15. CD31 Antibody Industry Chain
Figure 16. CD31 Antibody Procurement Model
Figure 17. CD31 Antibody Sales Model
Figure 18. CD31 Antibody Sales Channels, Direct Sales, and Distribution
Figure 19. Monoclonal
Figure 20. Polyclonal
Figure 21. By Type, Global CD31 Antibody Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global CD31 Antibody Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 24. By Type, Global CD31 Antibody Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global CD31 Antibody Average Selling Price (ASP), 2018-2029, (US$/L)
Figure 26. Immunochemistry (IHC)
Figure 27. Immunofluorescence (IF)
Figure 28. Western Blot (WB)
Figure 29. Immunocytochemistry (ICC)
Figure 30. ELISA
Figure 31. Others
Figure 32. By Application, Global CD31 Antibody Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global CD31 Antibody Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 35. By Application, Global CD31 Antibody Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global CD31 Antibody Average Selling Price (ASP), 2018-2029, (US$/L)
Figure 37. By Region, Global CD31 Antibody Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global CD31 Antibody Sales Quantity Market Share, 2018-2029
Figure 39. North America CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America CD31 Antibody Consumption Value Market Share, 2022
Figure 41. Europe CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe CD31 Antibody Consumption Value Market Share, 2022
Figure 43. Asia Pacific CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific CD31 Antibody Consumption Value Market Share, 2022
Figure 45. South America CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America CD31 Antibody Consumption Value Market Share, 2022
Figure 47. Middle East & Africa CD31 Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 49. By Type, U.S. CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 52. By Type, Europe CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 54. China CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 55. By Type, China CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 58. By Type, Japan CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 61. By Type, South Korea CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 64. By Type, Southeast Asia CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 66. India CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 67. By Type, India CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, India CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 69. Middle East & Africa CD31 Antibody Sales Quantity, 2018-2029, (L)
Figure 70. By Type, Middle East & Africa CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, Middle East & Africa CD31 Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 72. Research Methodology
Figure 73. Breakdown of Primary Interviews
Figure 74. Bottom-up and Top-down Approaches
Figure 75. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|